The Center for Molecular Medicine in Montreux, Switzerland is the flagship clinic of RCLIN Group.
RCLIN Group operates a level two biosafety laboratory and manufactures molecular compounds and food supplements at RCLIN Pharma Ltd. in Malta.
RCLIN Group is an international business in the domain of life sciences headquartered in Montreux, Switzerland, which is founded and wholly owned by the Pruss Family. RCLIN Group is present via its subsidiaries in Switzerland, Malta and Ukraine and is supported by a network of partner clinics, laboratories and compounding pharmaceutical companies across Europe and in the United States.
RCLIN Group operates medical centers and laboratories in the domain of molecular medicine, maintains a network of world-renowned experts in medicine, biosciences and pharmacology, and produces personalized medications and food supplements at its own manufacturing facility.